Cyclodextrin News

HPBCD inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines

COVID-19 is marked by extensive damage to the respiratory system, often accompanied by systemic manifestations, due to both viral cytopathic

The 20th International Cyclodextrin Symposium will be held on June 13-17 2022 in Giardini Naxos (Messina, ITALY) jointly organized by

The patent application (1) with priority date of 09. March 2020 claims that methyl bCD preferably with DS 0.7 (Crysmeb)

A recent review of Jicsinszky et al. (2021) gave an overview on cyclodextrins’ benefits and limitations in various antiviral drug

As the International Cyclodextrin Symposium (Giardini Naxos, Sicily) has been postponed to 2022 an abridged virtual meeting was organized by

The webinar of CycloLab “Getting the best out of cyclodextrins” was held on Apr.15-16, 2021. Out of >500 registrations over

The review of Braga et al. describes the various roles of cyclodextrins (CDs) in vaccines againstviruses and in antiviral therapeutics

Previous reports have demonstrated that compounds based on sulfo derivatives of oligo- and polysaccharides possess high antiviral activity. In this

With the title “How cyclodextrins work: Five things we learned from Roquette“, Dental Tribune gives a summary on the roles